MedTrace Logo

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

NCT04499755 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-08-05

No results posted yet for this study

Summary

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Conditions

  • Brain Injuries

Interventions

DRUG

Nucleo CMP Forte

Nucleo CMP Forte twice daily for 6 weeks

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Abeer Salamah, Lecturer · Pediatrics department - Kafr-Elsheikh University

  • Mohamed Elbahnasawy, lecturer · Emergency Department- Tanta University.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2030-12-01
Completion
2030-12-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04499755 on ClinicalTrials.gov